Malaria CVD 36000; Gates INV090205

计划入组 32 人 · 首次发布于 2026 年 4 月 30 日

Vestibular Perception Gates Autonomic Responses to Sinusoidal Galvanic Vestibular Stimulation

计划入组 56 人 · 首次发布于 2026 年 7 月 20 日

Effect of Inferior Alveolar and Gow-Gates Nerve Block Techniques for Symptomatic Mandibular Molars

计划入组 150 人 · 首次发布于 2017 年 4 月 18 日

CCR8 (Integral Molecular)

DLL3(Molecular Partners)

Influenza therapeutics(Exscientia/Bill & Melinda Gates Foundation)

Molecular

Switzerland

BILL & MELINDA GATES FOUNDATION

Ethiopia

Molecular Templates

United States

Gate Bioscience Partners with Lilly in $856 Million Deal to Develop Novel Molecular Gate Therapeutics

Gate Bioscience Raises $65 Million Series B to Advance Novel Oral Molecular Gate Therapies into Clinical Trials

Gates Institute Advances Cell and Gene Therapy Programs with New Scientific Advisory Board and Clinical Trials